This company produces Bioalbumen®, an animal-free egg protein derived through precision fermentation. This ingredient offers the full functionality and nutrition of traditional egg whites, providing food manufacturers with a reliable and sustainable alternative. Bioalbumen® enhances supply chain resilience and supports ESG goals through reduced resource consumption compared to conventional egg production.
Funding
$56.3M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
EAFounders
Product
Problem
Conventional egg production faces challenges related to environmental sustainability, animal welfare, and supply chain reliability due to factors like avian flu. Traditional egg whites also present limitations in terms of consistent quality and scalability for various food industry applications.
Solution
Onego Bio produces Bioalbumen®, an animal-free egg white protein, using precision fermentation. This technology replicates the nutritional profile and functional properties of traditional egg whites without the need for animal agriculture. Bioalbumen® offers a sustainable and reliable alternative to conventional egg whites, addressing the growing demand for protein sources with a reduced environmental footprint. The resulting protein ingredient can be used in various food formulations, enhancing their appeal, performance, and sustainability.
Target Audience
The primary target audience includes food manufacturers, bakeries, and other companies seeking sustainable and animal-free protein ingredients for their products.
Features
- Nature-identical ovalbumin produced via precision fermentation
- Delivers the nutritional and functional qualities of egg whites
- Sustainable and reliable alternative to traditional egg whites
- Addresses environmental and animal welfare concerns
- Scalable production to meet growing protein demands